Skip to content
Clinical Trials – home
SlovakiaBack to Slovakia

Clinical trials in Levice – page 11

155 clinical trials in Levice, Slovakia. Every trial is listed in the EU Clinical Trials Register and updated daily.

SlovakiaOur site in SlovakiaKlinickeSkusky.sk(opens in a new tab)
Levice at a glance
155
clinical trials
  • Research sites0
Type of trial
Recruitment status
Quick filters

155 trials in Levice

Open in trial search

Study on the Safety and Effectiveness of Tovinontrine for Adults with Chronic Heart Failure with Reduced Ejection Fraction

Investigational
Countries:SlovakiaSlovakia
  • Participants:18–64 years · 65+ years
  • Substances:Tovinontrine
  • Sponsor:Cardurion Pharmaceuticals Inc.

Study on the Safety and Effectiveness of Betula Pollen Extract for Children and Adolescents Aged 5-17 with Birch Pollen Allergies and Possible Asthma

Registered drug
Countries:SlovakiaSlovakia
  • Participants:0–17 years
  • Substances:Betula Pollen Extract
  • Sponsor:Stallergenes

Study on Tiragolumab and Atezolizumab for Patients with Resected Stage IIB-IIIB Non-Small Cell Lung Cancer After Chemotherapy

Registered drug
Countries:SlovakiaSlovakia
  • Participants:18–64 years · 65+ years
  • Sponsor:F. Hoffmann-La Roche AG

Study of BP05 and Ranibizumab Efficacy and Safety in Patients with Wet Age-Related Macular Degeneration

Registered drugNo placebo
Countries:SlovakiaSlovakia
  • Participants:18–64 years · 65+ years
  • Substances:Ranibizumab
  • Sponsor:Curateq Biologics Private Limited

Study of Encorafenib, Binimetinib, and Pembrolizumab for Patients with BRAF V600E/K Mutation-Positive Melanoma After Anti-PD-1 Therapy

Registered drugNo placebo
Countries:SlovakiaSlovakia
  • Participants:18–64 years · 65+ years
  • Substances:Binimetinib
  • Sponsor:Pfizer Inc.

Study on PF-07220060, Letrozole, and Fulvestrant for Patients with Advanced Breast Cancer, Prostate Cancer, and Other Solid Tumors

Registered drugNo placebo
Countries:SlovakiaSlovakia
  • Participants:18–64 years · 65+ years
  • Substances:Fulvestrant
  • Sponsor:Pfizer Inc.

Cardiac failure

Not recruiting

Study on Balcinrenone and Dapagliflozin for Patients with Heart Failure and Kidney Problems

Registered drug
Countries:SlovakiaSlovakia
  • Participants:18–64 years · 65+ years
  • Substances:Balcinrenone
  • Sponsor:AstraZeneca AB

Crohn's disease

Not recruiting

Study on the Effectiveness and Safety of Risankizumab for Patients with Moderate to Severe Crohn's Disease

Investigational
Countries:SlovakiaSlovakia
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Risankizumab
  • Sponsor:AbbVie Deutschland GmbH & Co. KG

Study on the Effectiveness and Safety of Remibrutinib Compared to Teriflunomide for Patients with Relapsing Multiple Sclerosis

Registered drug
Countries:SlovakiaSlovakia
  • Participants:18–64 years
  • Substances:Charcoal, Activated
  • Sponsor:Novartis Pharma AG

Colitis ulcerative

Not recruiting

Study on the Effectiveness and Safety of Risankizumab for Patients with Moderate to Severe Ulcerative Colitis

Investigational
Countries:SlovakiaSlovakia
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Risankizumab
  • Sponsor:AbbVie Deutschland GmbH & Co. KG

Study of Capivasertib and Abiraterone for Patients with Metastatic Hormone-Sensitive Prostate Cancer with PTEN Deficiency

Registered drug
Countries:SlovakiaSlovakia
  • Participants:18–64 years · 65+ years
  • Substances:Abiraterone Acetate
  • Sponsor:AstraZeneca AB

Study on Ofatumumab for Patients with Relapsing Multiple Sclerosis Transitioning from Fumarate-Based Therapies or Fingolimod

Registered drugNo placebo
Countries:SlovakiaSlovakia
  • Participants:18–64 years
  • Substances:Ofatumumab
  • Sponsor:Novartis Pharma AG

Other cities in Slovakia

The busiest research cities in the country

All 88 cities in Slovakia

Clinical research in Levice

What the registry says about research in the country

01 Cardiovascular Diseases

In Levice, cardiovascular disease research focuses on preventing serious events such as stroke, heart attack, and other vascular complications. These studies are designed to assess new options for stroke prevention, atherosclerotic cardiovascular disease, and related risk reduction.

  • Acute ischemic stroke and high-risk transient ischemic attack
  • Atrial fibrillation with prevention of stroke or systemic embolism
  • Atherosclerotic cardiovascular disease and systemic inflammation
  • High LDL cholesterol and broader cardiovascular risk

The trials are mainly evaluating whether new treatments can improve protection against major cardiovascular events and support better long-term outcomes.

02 Respiratory Tract Diseases

A large share of the clinical research in Levice is centered on asthma and chronic obstructive pulmonary disease. These studies explore ways to improve breathing control, reduce flare-ups, and slow the decline in lung function in people with persistent respiratory symptoms.

  • Moderate to severe asthma and uncontrolled asthma
  • Chronic obstructive pulmonary disease and chronic bronchitis
  • Asthma with frequent exacerbations
  • Severe COPD outcomes and lung function decline

Overall, the research is aimed at testing new therapies and combination treatments that may help people breathe more easily and stay stable for longer.

03 Nutritional and Metabolic Diseases

Clinical trials in this area examine overweight, obesity, type 2 diabetes, and hyperlipidemia. The goal is to better understand treatment approaches that may support weight reduction and improve metabolic health.

  • Overweight or obesity with type 2 diabetes
  • Hyperlipidemia and elevated cardiovascular risk
  • Weight management in people with metabolic disease
  • Metabolic risk linked to heart and vascular complications

These studies are mainly testing whether newer therapies can improve key health markers and reduce the burden of metabolic disease.

04 Skin and Connective Tissue Diseases

Research in skin and connective tissue diseases is represented by studies on chronic spontaneous urticaria. The main purpose is to evaluate treatments that may improve symptom control and provide longer-lasting relief for people with persistent allergic skin disease.

  • Chronic spontaneous urticaria
  • Long-term symptom control
  • Relapse prevention and treatment durability

This area adds a focused immunology component to the clinical trial landscape in Levice.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.